The Nova Trial, like other clinical trials, is conducted in multiple phases:
Phase I: Tests the safety and optimal dosing of the new treatment in a small group of participants. Phase II: Expands the participant pool to evaluate the effectiveness and further assess safety. Phase III: Compares the new treatment to the current standard treatment in a larger group of participants to confirm efficacy and monitor side effects.